Supernus Pharmaceuticals, Inc. (SUPN)
50.85
-0.50
(-0.97%)
USD |
NASDAQ |
Feb 20, 14:22
Supernus Pharmaceuticals EPS Diluted (TTM) : -0.3408 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 8.806 |
| Catalyst Pharmaceuticals, Inc. | 1.714 |
| Vertex Pharmaceuticals, Inc. | 15.33 |
| Krystal Biotech, Inc. | 6.844 |
| Moderna, Inc. | -7.262 |